Business Description
Optus Pharmaceutical Co Ltd
ISIN : KR7131030009
Compare
Compare
Traded in other countries / regions
131030.Korea IPO Date
2010-12-03Description
Optus Pharmaceutical Co Ltd is engaged in the manufacturing of finished medicaments.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 33.06 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.12 | |||||
| Interest Coverage | 65.81 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 6.15 | |||||
| Beneish M-Score | -2.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.4 | |||||
| 3-Year EBITDA Growth Rate | -4.3 | |||||
| 3-Year EPS without NRI Growth Rate | -11.2 | |||||
| 3-Year FCF Growth Rate | -5.7 | |||||
| 3-Year Book Growth Rate | 5.9 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.84 | |||||
| 9-Day RSI | 51.04 | |||||
| 14-Day RSI | 51.04 | |||||
| 6-1 Month Momentum % | 21.24 | |||||
| 12-1 Month Momentum % | -3.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.02 | |||||
| Quick Ratio | 6.02 | |||||
| Cash Ratio | 5.24 | |||||
| Days Inventory | 143.86 | |||||
| Days Sales Outstanding | 42.33 | |||||
| Days Payable | 17.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.6 | |||||
| Dividend Payout Ratio | 0.18 | |||||
| Forward Dividend Yield % | 1.6 | |||||
| 5-Year Yield-on-Cost % | 1.62 | |||||
| 3-Year Average Share Buyback Ratio | 1.7 | |||||
| Shareholder Yield % | 1.38 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57.2 | |||||
| Operating Margin % | 11.3 | |||||
| Net Margin % | 14.86 | |||||
| FCF Margin % | 12.58 | |||||
| ROE % | 8.36 | |||||
| ROA % | 7.58 | |||||
| ROIC % | 8.96 | |||||
| ROC (Joel Greenblatt) % | 23.74 | |||||
| ROCE % | 10.02 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 8.82 | |||||
| PE Ratio without NRI | 11.03 | |||||
| Shiller PE Ratio | 8.27 | |||||
| Price-to-Owner-Earnings | 10.03 | |||||
| PS Ratio | 1.31 | |||||
| PB Ratio | 0.71 | |||||
| Price-to-Tangible-Book | 0.71 | |||||
| Price-to-Free-Cash-Flow | 10.42 | |||||
| Price-to-Operating-Cash-Flow | 7.63 | |||||
| EV-to-EBIT | 2.21 | |||||
| EV-to-EBITDA | 1.67 | |||||
| EV-to-Revenue | 0.4 | |||||
| EV-to-FCF | 3.29 | |||||
| Price-to-Projected-FCF | 0.53 | |||||
| Price-to-Median-PS-Value | 0.48 | |||||
| Price-to-Graham-Number | 0.59 | |||||
| Price-to-Net-Current-Asset-Value | 1.24 | |||||
| Price-to-Net-Cash | 1.78 | |||||
| Earnings Yield (Greenblatt) % | 45.29 | |||||
| FCF Yield % | 9.56 | |||||
| Forward Rate of Return (Yacktman) % | 0.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Optus Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 72,426.447 | ||
| EPS (TTM) (â‚©) | 708 | ||
| Beta | 0.45 | ||
| Volatility % | 41.1 | ||
| 14-Day RSI | 51.04 | ||
| 14-Day ATR (â‚©) | 295.509626 | ||
| 20-Day SMA (â‚©) | 6135 | ||
| 12-1 Month Momentum % | -3.35 | ||
| 52-Week Range (â‚©) | 4465 - 9550 | ||
| Shares Outstanding (Mil) | 15.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Optus Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Optus Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Optus Pharmaceutical Co Ltd Frequently Asked Questions
What is Optus Pharmaceutical Co Ltd(XKRX:131030)'s stock price today?
The current price of XKRX:131030 is â‚©6240.00. The 52 week high of XKRX:131030 is â‚©9550.00 and 52 week low is â‚©4465.00.
When is next earnings date of Optus Pharmaceutical Co Ltd(XKRX:131030)?
The next earnings date of Optus Pharmaceutical Co Ltd(XKRX:131030) is .
Does Optus Pharmaceutical Co Ltd(XKRX:131030) pay dividends? If so, how much?
The Dividend Yield %  of Optus Pharmaceutical Co Ltd(XKRX:131030) is 1.6% (As of Today), Highest Dividend Payout Ratio of Optus Pharmaceutical Co Ltd(XKRX:131030) was 0.33. The lowest was 0.11. And the median was 0.15. The  Forward Dividend Yield % of Optus Pharmaceutical Co Ltd(XKRX:131030) is 1.6%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers